Joseph S McCracken

CIK 1632454 · last filed 2026-02-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

4

Total Filings

43

Lifetime Open-Market Net

$531.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SVRA Director 302,644 $5.26 $1.59M $428.1K 15 2026-02-17
LUMOS PHARMA, INC. (LUMO) Delisted Director 0 $4.34 $0 $103.8K 9 2024-12-13
Kindred Biosciences, Inc. (KIN) Delisted Director $9.25 $0 6 2021-08-30
Nexvet Biopharma plc (NVET) Delisted Director 12,800 $0 12 2017-07-05

Recent Filings · Page 3 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-04-07 LUMOS PHARMA, INC. (LUMO) Delisted Grant (A) +709 $0 EDGAR
2020-01-22 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) $0 EDGAR
2019-12-26 SVRA Grant (A) $0 EDGAR
2019-07-08 SVRA Exer (M) +39,506 $44.6K EDGAR
2019-02-05 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) $0 EDGAR
2018-12-14 SVRA Grant (A) $0 EDGAR
2018-06-26 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) $0 EDGAR
2018-04-24 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) $0 EDGAR
2017-12-19 SVRA Grant (A) $0 EDGAR
2017-08-02 Disp (D) −16,400 -$110.2K
Showing 2130 of 43
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.